Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
H Partners Management activist fund; bought Nov 6 (700K @ $10.00), Nov 9 (350K @ $10.86), Nov 10 (400K @ $10.32). Stake raised to 6.35M shares. Current price $10.16 (-1.4% from blended avg $10.30).
OrbiMed funds (Private Investments VII + Genesis Master Fund) accumulated Nov 6 ($77K + $311K), Nov 9 ($33K + $132K), Nov 10 ($175K + $17K). Blended avg ~$8.08. Current price $7.99 (-1.1% from blended avg).
AIThe day in insider buying
SEC Form 4 Insider Scan — November 11, 2026
Scanned the last 24 hours of EDGAR Form 4 filings (353 filings dated 2026-11-10). 4 qualifying buys (≥ $250K, transaction type P) totalling $20.5M.
Headline Filings
FUN — Rehan Jaffer (Director, H Partners Management) bought 1,450,000 shares ≈ $14.9M at ~$10.30 blended avg; now $10.16 (-1.4% since buy). Multi-day purchase Nov 6–10 by activist fund H Partners, raising their stake to 6.35M shares. (filing)
TXO — Bob R. Simpson (Director & 10% Owner, GP Chairman) bought 232,839 units ≈ $3.08M at ~$13.22 blended avg; now $13.73 (+3.9% since buy). Consistent daily buying Nov 6–10 by the company's founder/chairman. (filing)
PSEC — John F. Barry III (CEO & 10% Owner) bought 1,222,704 shares ≈ $1.73M at $1.41; now $1.50 (+6.2% since buy). CEO accumulation in BDC stock at multi-year lows. (filing)
ETRA — Carl L. Gordon (Director & 10% Owner via OrbiMed) bought 92,116 shares ≈ $744K at ~$8.08 blended avg; now $7.99 (-1.1% since buy). OrbiMed funds accumulated across Nov 6–10. (filing)
Notes
Theme: Small/mid-cap value and income names dominate. The largest buy is activist H Partners deploying $14.9M into Six Flags Entertainment (FUN) over five consecutive sessions — a strong conviction signal. TXO Partners founder Bob Simpson's consistent daily buying ($3.1M total) is classic controlled-accumulation behavior from a 10%+ owner. PSEC CEO John Barry buying near $1.41 in a BDC with elevated yield signals near-bottom confidence. OrbiMed's ETRA adds are typical of institutional healthcare investors building positions in a micro-cap biotech.
Notable near-miss: ATEC (Alphatec Holdings) Director Keith Valentine — 35,000 shares at $6.93 ≈ $242K, just under the $250K threshold.
Prices as of pre-market Nov 11, 2026 (market not yet open).
Most-bought stocks, last 30 days
CRBG$115M · 12 buys, 2 insidersCorebridge Financial, Inc.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.